» Articles » PMID: 9748212

Control of Cell Cycle Progression by Fibronectin Matrix Architecture

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Sep 25
PMID 9748212
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Developmental patterning and differentiation, maintenance of parenchymal cell function, and the size, shape, and invasiveness of tumors are all orchestrated by cell interactions with the extracellular matrix. Here we show that the fibrillar structure of fibronectin (FN) matrix encodes essential regulatory cues and controls cell proliferation and signaling through changes in matrix architecture. A matrix assembled from native FN stimulated cell growth. In contrast, a mutant FN (FNDeltaIII1-7) that contains all known cell binding motifs but forms a structurally distinct matrix inhibited progression from G0/G1 into S phase. Furthermore, FNDeltaIII1-7 suppressed the stimulatory capacity of native FN and induced different levels of tyrosine phosphorylation of pp125(FAK). The differential effects on cell growth were ablated by blocking formation of matrix fibrils. Thus, modification of matrix architecture provides a novel approach to control cell proliferation.

Citing Articles

Delivery technologies for therapeutic targeting of fibronectin in autoimmunity and fibrosis applications.

Bonadio J, Bashiri G, Halligan P, Kegel M, Ahmed F, Wang K Adv Drug Deliv Rev. 2024; 209:115303.

PMID: 38588958 PMC: 11111362. DOI: 10.1016/j.addr.2024.115303.


Direct antitumoral effects of sulfated fucans isolated from echinoderms: a possible role of neuropilin-1/β1 integrin endocytosis and focal adhesion kinase degradation.

Lima A, Mignone V, Vardiero F, Kozlowski E, Fernandes L, Motta J Glycobiology. 2023; 33(9):715-731.

PMID: 37289485 PMC: 10627248. DOI: 10.1093/glycob/cwad044.


The influence of CD26 and CD26 fibroblasts on the regeneration of human dermo-epidermal skin substitutes.

Michalak-Micka K, Klar A, Dasargyri A, Biedermann T, Reichmann E, Moehrlen U Sci Rep. 2022; 12(1):1944.

PMID: 35121765 PMC: 8816920. DOI: 10.1038/s41598-022-05309-5.


Enhancing the Surface Properties of a Bioengineered Anterior Cruciate Ligament Matrix for Use with Point-of-Care Stem Cell Therapy.

Yu X, Mengsteab P, Narayanan G, Nair L, Laurencin C Engineering (Beijing). 2021; 7(2):153-161.

PMID: 34136308 PMC: 8205060.


Substratum stiffness signals through integrin-linked kinase and β1-integrin to regulate midbody proteins and abscission during EMT.

Rabie E, Zhang S, Dunn C, Nelson C Mol Biol Cell. 2021; 32(18):1664-1676.

PMID: 34038147 PMC: 8684726. DOI: 10.1091/mbc.E21-02-0072.